ProThera Biologics, based in Providence, RI, is a biopharmaceutical company that is revolutionizing the treatment of severe inflammation. With a focus on developing a new class of human plasma proteins, ProThera Biologics aims to restore immune regulation and combat damaging inflammation in patients with life-threatening immune responses that are unresponsive to current medications.
Through their research, ProThera Biologics has identified the Inter-alpha inhibitor proteins (IAIP) as crucial anti-inflammatory proteins with immense potential to treat severe inflammatory diseases. Their groundbreaking approach offers a first-in-class, life-saving medicine that can halt and reverse the course of these debilitating conditions, providing hope for patients in need.
Generated from the website